Annual Total Expenses
$267.32 M
+$72.06 M+36.91%
31 December 2023
Summary:
Pharming Group NV annual total expenses is currently $267.32 million, with the most recent change of +$72.06 million (+36.91%) on 31 December 2023. During the last 3 years, it has risen by +$131.40 million (+96.68%). PHAR annual total expenses is now at all-time high.PHAR Total Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Total Expenses
$70.74 M
-$6.47 M-8.38%
30 September 2024
Summary:
Pharming Group NV quarterly total expenses is currently $70.74 million, with the most recent change of -$6.47 million (-8.38%) on 30 September 2024. Over the past year, it has increased by +$5.99 million (+9.25%). PHAR quarterly total expenses is now -27.11% below its all-time high of $97.05 million, reached on 31 December 2023.PHAR Quarterly Total Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PHAR Total Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +36.9% | +9.3% |
| 3 y3 years | +96.7% | +29.4% |
| 5 y5 years | +140.6% | +155.8% |
PHAR Total Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +96.7% | -27.1% | +118.8% |
| 5 y | 5 years | at high | +140.6% | -27.1% | +155.8% |
| alltime | all time | at high | +1307.3% | -27.1% | +1826.1% |
Pharming Group NV Total Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $70.74 M(-8.4%) |
| June 2024 | - | $77.21 M(+7.4%) |
| Mar 2024 | - | $71.90 M(-25.9%) |
| Dec 2023 | $267.32 M(+36.9%) | $97.05 M(+49.9%) |
| Sept 2023 | - | $64.75 M(+30.6%) |
| June 2023 | - | $49.60 M(-11.8%) |
| Mar 2023 | - | $56.20 M(-23.2%) |
| Dec 2022 | $195.25 M(+8.6%) | $73.17 M(+57.5%) |
| Sept 2022 | - | $46.47 M(+43.8%) |
| June 2022 | - | $32.33 M(-26.2%) |
| Mar 2022 | - | $43.79 M(-10.8%) |
| Dec 2021 | $179.86 M(+32.3%) | $49.10 M(-10.2%) |
| Sept 2021 | - | $54.68 M(+40.9%) |
| June 2021 | - | $38.80 M(+4.1%) |
| Mar 2021 | - | $37.28 M(-1.4%) |
| Dec 2020 | $135.92 M(+12.2%) | $37.80 M(+8.6%) |
| Sept 2020 | - | $34.82 M(+14.6%) |
| June 2020 | - | $30.38 M(-7.7%) |
| Mar 2020 | - | $32.92 M(+0.1%) |
| Dec 2019 | $121.14 M(+9.0%) | $32.88 M(+18.9%) |
| Sept 2019 | - | $27.66 M(-20.5%) |
| June 2019 | - | $34.80 M(+34.8%) |
| Mar 2019 | - | $25.81 M(-21.7%) |
| Dec 2018 | $111.12 M(+36.8%) | $32.95 M(+16.6%) |
| Sept 2018 | - | $28.26 M(+19.4%) |
| June 2018 | - | $23.67 M(-9.8%) |
| Mar 2018 | - | $26.23 M(-11.3%) |
| Dec 2017 | $81.23 M(+181.8%) | $29.56 M(+37.8%) |
| Sept 2017 | - | $21.45 M(+20.3%) |
| June 2017 | - | $17.83 M(+44.0%) |
| Mar 2017 | - | $12.38 M(+44.8%) |
| Dec 2016 | $28.83 M | $8.55 M(+13.9%) |
| Sept 2016 | - | $7.51 M(+12.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2016 | - | $6.67 M(+9.4%) |
| Mar 2016 | - | $6.10 M(-0.2%) |
| Dec 2015 | $25.87 M(+16.2%) | $6.12 M(-13.6%) |
| Sept 2015 | - | $7.08 M(-4.9%) |
| June 2015 | - | $7.44 M(+42.4%) |
| Mar 2015 | - | $5.23 M(+2.0%) |
| Dec 2014 | $22.26 M(+17.2%) | $5.13 M(-18.4%) |
| Sept 2014 | - | $6.28 M(+33.7%) |
| June 2014 | - | $4.70 M(-23.7%) |
| Mar 2014 | - | $6.16 M(+3.0%) |
| Dec 2013 | $19.00 M(-46.4%) | $5.98 M(+22.5%) |
| Sept 2013 | - | $4.88 M(+9.3%) |
| June 2013 | - | $4.47 M(+21.6%) |
| Mar 2013 | - | $3.67 M(-63.7%) |
| Dec 2012 | $35.47 M(+27.5%) | $10.12 M(+32.8%) |
| Sept 2012 | - | $7.62 M(-26.8%) |
| June 2012 | - | $10.41 M(+42.3%) |
| Mar 2012 | - | $7.31 M(+30.7%) |
| Dec 2011 | $27.82 M(-3.7%) | $5.60 M(-26.5%) |
| Sept 2011 | - | $7.61 M(-0.6%) |
| June 2011 | - | $7.65 M(+9.9%) |
| Mar 2011 | - | $6.96 M(-25.5%) |
| Dec 2010 | $28.90 M(-28.0%) | $9.34 M(+45.9%) |
| Sept 2010 | - | $6.41 M(+15.2%) |
| June 2010 | - | $5.56 M(-16.8%) |
| Mar 2010 | - | $6.68 M(-22.4%) |
| Dec 2009 | $40.14 M(+11.1%) | $8.61 M(-14.4%) |
| Sept 2009 | - | $10.05 M(-15.4%) |
| June 2009 | - | $11.88 M(+36.5%) |
| Mar 2009 | - | $8.70 M |
| Dec 2008 | $36.12 M(-0.9%) | - |
| Dec 2007 | $36.46 M(+55.0%) | - |
| Dec 2006 | $23.52 M(+5.4%) | - |
| Dec 2005 | $22.32 M | - |
FAQ
- What is Pharming Group NV annual total expenses?
- What is the all time high annual total expenses for Pharming Group NV?
- What is Pharming Group NV annual total expenses year-on-year change?
- What is Pharming Group NV quarterly total expenses?
- What is the all time high quarterly total expenses for Pharming Group NV?
- What is Pharming Group NV quarterly total expenses year-on-year change?
What is Pharming Group NV annual total expenses?
The current annual total expenses of PHAR is $267.32 M
What is the all time high annual total expenses for Pharming Group NV?
Pharming Group NV all-time high annual total expenses is $267.32 M
What is Pharming Group NV annual total expenses year-on-year change?
Over the past year, PHAR annual total expenses has changed by +$72.06 M (+36.91%)
What is Pharming Group NV quarterly total expenses?
The current quarterly total expenses of PHAR is $70.74 M
What is the all time high quarterly total expenses for Pharming Group NV?
Pharming Group NV all-time high quarterly total expenses is $97.05 M
What is Pharming Group NV quarterly total expenses year-on-year change?
Over the past year, PHAR quarterly total expenses has changed by +$5.99 M (+9.25%)